We have previously observed, in novel p300 S89A knock-in mice that displayed enhanced Wnt/CBP/beta-catenin signaling [6], that major metabolic defects existed and midnolin was one of the most significantly differentially expressed genes in livers [7], pointing to a role for midnolin in liver disease. The gene discussed is MIDN; the disease is liver disorder.